Shares of Eli Lilly and Company (LLY) closed at $1,416.54 on October 31, 2026, marking a 3.17% gain over the prior 24-hour period. The move extended a stretch of sustained appreciation that has lifted the stock across multiple timeframes.
Over the past seven days, LLY advanced 11.17%, while the 30-day return reached 22.19%, reflecting broad and consistent buying pressure in the pharmaceutical giant's shares. The stock's climb over the month represents one of the more notable moves in the large-cap healthcare space during that window.
Eli Lilly's market capitalization stood at $1,224.46 billion as of the session's close, keeping the company among the most valuable publicly traded corporations by that measure. The figure reflects the cumulative effect of the recent price appreciation applied across the company's outstanding share count.
The combination of short- and medium-term gains indicates that momentum in LLY has built progressively over the 30-day period rather than concentrating in a single session. Whether that trend continues will depend on upcoming data points not yet reflected in the current figures.
